Evidence map›Paper›PMID 40940435›Full record

ArticleScientific reports2025

Characteristics related to biomarkers of neutrophil, eosinophil, and mast cell activation.

Anna Sivander, Maria Hårdstedt, Elisabet Nerpin, Robert Movérare, Anders Sjölander, Christer Janson, Andrei Malinovschi

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anna SivanderDepartment of Medical Sciences, Clinical Physiology, Uppsala University, Uppsala, Sweden. anna.sivander@regiondalarna.se.
Maria HårdstedtDepartment of Medical Sciences, Clinical Physiology, Uppsala University, Uppsala, Sweden.
Elisabet NerpinDepartment of Medical Sciences, Clinical Physiology, Uppsala University, Uppsala, Sweden.
Robert MovérareDepartment of Medical Sciences, Respiratory-, Allergy- and Sleep Research, Uppsala University, Uppsala, Sweden.
Anders SjölanderThermo Fisher Scientific, Uppsala, Sweden.
Christer JansonDepartment of Medical Sciences, Respiratory-, Allergy- and Sleep Research, Uppsala University, Uppsala, Sweden.
Andrei MalinovschiDepartment of Medical Sciences, Clinical Physiology, Uppsala University, Uppsala, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic inflammation is important in many medical conditions. Activation markers of inflammatory cells can be quantified, but are less studied. Therefore, we studied individual characteristics and diseases in relation to neutrophil gelatinase-associated lipocalin (NGAL) and myeloperoxidase (MPO), both for neutrophils, eosinophil-derived neurotoxin (EDN), eosinophil cationic protein (ECP), and mast cell tryptase. Spirometry and serum biomarkers were assessed in 498 participants (252 males) aged ≥ 40 years from the Uppsala center of the population-based Burden of Obstructive Lung Disease study. Higher MPO, NGAL and EDN levels related to heart disease. Higher ECP and EDN levels were both related to asthma while higher EDN related to male sex and atopy. Higher tryptase levels were found in subjects with obesity, chronic airflow limitation (CAL), or hypertension. In multivariate analyses, subjects with heart disease had 22.1% (95% confidence interval 4.1%, 43.3%) higher MPO, 19.3% (7.8%, 31.9%) higher NGAL, and 23.2% (3.0%, 47.3%) higher EDN than subjects without heart disease. The association between CAL and tryptase was not consistent after adjustment for age and BMI as continuous variables. The higher EDN levels in heart disease is a novel finding that require further studies to elucidate the clinical importance.

Indexed as

BiomarkersEosinophilsMast CellsNeutrophilsAdultAgedEosinophil Cationic ProteinEosinophil-Derived NeurotoxinFemaleHumansLipocalin-2MaleMiddle AgedPeroxidaseTryptasesBiomarkersEosinophil Cationic ProteinEosinophil-Derived NeurotoxinLCN2 protein, humanLipocalin-2PeroxidaseTryptasesBiomarkersDiseaseEosinophilMast cellNeutrophil

Identifiers

PMID40940435
PMCPMC12432152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.